The company's core technologies and capabilities are to scientifically and effectively develop drugs with innovative mechanisms of action, featuring clinical differentiation and meeting clinical needs, supported by a comprehensive strategy covering new drug molecular discovery, early evaluation, and clinical development based on AI-assisted design and chemical genomics technology platform.
